&nbsp;

Dec 1969

Regimen

AVD+NIVL

Cancer Type:

Hematologic,

Lymphoma - Hodgkin

Intent: Curative

Drugs Used:

nivolumab (Unfunded),

Quick Link(s):

Regimen Monograph

Document

[PDF]

Accompagnement-dans-votre-parcours-de-soins-palliatifs.pdf

Dec 1969

Document

[PDF]

ACCUBreastFactSheet-Inuit.pdf

Dec 1969

Document

[PDF]

RQAProgramManual.pdf

New

Jul 2025

Drug

asciminib

Other Name(s): Scemblix™

Quick Link(s):

Jul 2025

Regimen

ABIRPRED

Cancer Type:

Genitourinary,

Prostate

Intent: Adjuvant, Curative

Funding:

ODB - General Benefit

abiraterone

ODB - General Benefit

prednisone

Drugs Used:

abiraterone,

prednisone

Quick Link(s):

Regimen Monograph

Jul 2025

Regimen

RITU(DESENS)

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL),

Leukemia - Chronic Lymphocytic (CLL),

Leukemia - Hairy Cell,

Lymphoma - Hodgkin,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Curative, Palliative

Drugs Used:

trastuzumab

Quick Link(s):

Regimen Monograph

Jul 2025

Regimen

AZCTIVOS

Cancer Type:

Hematologic,

Leukemia - Acute Myeloid (AML)

Intent: Curative

Funding:

New Drug Funding Program

Azacitidine in combination with Ivosidenib (Outpatient) - Previously Untreated Acute Myeloid Leukemia

Exceptional Access Program

Ivosidenib in combination with Azacitidine (Outpatient) - Previously Untreated Acute Myeloid Leukemia

Drugs Used:

ivosidenib,

azaCITIDine

Quick Link(s):

Regimen Monograph

New

Sep 2025

Drug

azaCITIDine

Other Name(s): Vidaza®

Quick Link(s):

Updated

Sep 2025

Drug

alectinib

Other Name(s): Alecensaro®

Quick Link(s):

Updated

Sep 2025

Regimen

ALEC

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

Exceptional Access Program

alectinib - Treatment of ALK-positive locally advanced or metastatic non-small cell lung cancer, according to criteria

Drugs Used:

alectinib